Lifevantage Free Cash Flow 2012-2026 | LFVN
Lifevantage free cash flow from 2012 to 2026. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
| Lifevantage Annual Free Cash Flow | |
|---|---|
| 2025 | 10.51 |
| 2024 | 9.95 |
| 2023 | 3.77 |
| 2022 | 6.43 |
| 2021 | 12.54 |
| 2020 | 15.65 |
| 2019 | 15.28 |
| 2018 | 8.61 |
| 2017 | 5.54 |
| 2016 | 5.47 |
| 2015 | 12.06 |
| 2014 | 10.21 |
| 2013 | 5.58 |
| 2012 | 17.20 |
| 2011 | 4.56 |
| Lifevantage Quarterly Free Cash Flow | |
|---|---|
| 2026-03-31 | |
| 2025-12-31 | |
| 2025-09-30 | -2.74 |
| 2025-06-30 | 10.51 |
| 2025-03-31 | 9.68 |
| 2024-12-31 | 7.78 |
| 2024-09-30 | -0.93 |
| 2024-06-30 | 9.95 |
| 2024-03-31 | 7.65 |
| 2023-12-31 | 4.85 |
| 2023-09-30 | 3.63 |
| 2023-06-30 | 3.77 |
| 2023-03-31 | 0.51 |
| 2022-12-31 | -1.94 |
| 2022-09-30 | -2.07 |
| 2022-06-30 | 6.43 |
| 2022-03-31 | 3.92 |
| 2021-12-31 | 3.61 |
| 2021-09-30 | 0.09 |
| 2021-06-30 | 12.54 |
| 2021-03-31 | 4.64 |
| 2020-12-31 | 3.31 |
| 2020-09-30 | -2.01 |
| 2020-06-30 | 15.65 |
| 2020-03-31 | 6.87 |
| 2019-12-31 | 4.13 |
| 2019-09-30 | -4.21 |
| 2019-06-30 | 15.28 |
| 2019-03-31 | 9.12 |
| 2018-12-31 | 6.67 |
| 2018-09-30 | 2.28 |
| 2018-06-30 | 8.61 |
| 2018-03-31 | 4.42 |
| 2017-12-31 | 2.57 |
| 2017-09-30 | 1.33 |
| 2017-06-30 | 5.54 |
| 2017-03-31 | 4.16 |
| 2016-12-31 | 4.86 |
| 2016-09-30 | 2.79 |
| 2016-06-30 | 5.47 |
| 2016-03-31 | 5.70 |
| 2015-12-31 | 8.17 |
| 2015-09-30 | 2.84 |
| 2015-06-30 | 12.06 |
| 2015-03-31 | 7.86 |
| 2014-12-31 | 7.10 |
| 2014-09-30 | 4.83 |
| 2014-06-30 | 10.21 |
| 2014-03-31 | 8.51 |
| 2013-12-31 | 6.26 |
| 2013-09-30 | 4.56 |
| 2013-06-30 | 5.58 |
| 2013-03-31 | 5.44 |
| 2012-12-31 | 2.49 |
| 2012-09-30 | -0.65 |
| 2012-06-30 | 17.20 |
| 2012-03-31 | 9.92 |
| 2011-12-31 | 7.03 |
| 2011-09-30 | 2.98 |
| 2011-06-30 | 4.56 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $0.053B | $0.229B |
| Lifevantage Corporation is a health and nutrition company. The company is the maker of Protandim(R), the Nrf2 Synergizer(R) patented dietary supplement, the TrueScience(TM) Anti-Aging Skin Care Regimen, Canine Health and the AXIO(TM) energy product line. Lifevantage Corporation is headquartered in Salt Lake City, Utah. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $106.025B | 23.03 |
| Cardinal Health (CAH) | United States | $50.715B | 22.43 |
| Becton Dickinson (BDX) | United States | $43.913B | 11.10 |
| West Pharmaceutical Services (WST) | United States | $18.493B | 35.19 |
| Straumann Holding AG (SAUHY) | Switzerland | $16.902B | 0.00 |
| Cooper (COO) | United States | $13.894B | 16.52 |
| Align Technology (ALGN) | United States | $12.400B | 21.09 |
| Henry Schein (HSIC) | United States | $8.645B | 15.16 |
| Merit Medical Systems (MMSI) | United States | $4.072B | 19.84 |
| DENTSPLY SIRONA (XRAY) | United States | $2.339B | 7.36 |
| STAAR Surgical (STAA) | United States | $1.309B | 0.00 |
| CONMED (CNMD) | United States | $1.107B | 7.97 |
| Pro-Dex (PDEX) | United States | $0.165B | 19.65 |
| Axe Compute (AGPU) | United States | $0.022B | 0.00 |